TRAIL and other TRAIL receptor agonists as novel cancer therapeutics.

Falschlehner, Christina

TRAIL and other TRAIL receptor agonists as novel cancer therapeutics. [electronic resource] - Advances in experimental medicine and biology 2009 - 195-206 p. digital

Publication Type: Journal Article; Review

0065-2598

10.1007/978-0-387-89520-8_14 doi


Apoptosis
Clinical Trials as Topic
Humans
Neoplasms--pathology
Receptors, TNF-Related Apoptosis-Inducing Ligand--agonists
TNF-Related Apoptosis-Inducing Ligand--metabolism